Understand Abnormal Uterine Bleeding (AUB), also known as Dysfunctional Uterine Bleeding or Menorrhagia. This guide provides information on AUB diagnosis, clinical documentation, and medical coding for healthcare professionals. Learn about Menorrhagia symptoms, causes, and treatment options. Improve your clinical documentation and medical coding accuracy with this comprehensive resource for AUB.
Also known as
Excessive, frequent, and irregular menstruation
Covers various abnormal uterine bleeding disorders.
Other abnormal uterine bleeding
Includes unspecified abnormal bleeding and postmenopausal bleeding.
Unspecific abnormal vaginal bleeding
Used when a more specific diagnosis is not available.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the AUB due to an underlying medical condition (e.g., thyroid disorder, coagulopathy)?
Yes
Specify the underlying condition.
No
Is the AUB related to pregnancy, childbirth or the puerperium?
When to use each related code
| Description |
|---|
| Abnormal bleeding from the uterus. |
| Heavy menstrual bleeding. |
| Painful menstruation. |
Coding AUB without specifying cause (e.g., structural vs. nonstructural) leads to inaccurate severity and treatment reflection.
Incorrectly coding menorrhagia (heavy bleeding) as general AUB can underrepresent the clinical picture for quality metrics.
Coding AUB without sufficient clinical documentation supporting the diagnosis can trigger claim denials and compliance issues.
Q: What is the most effective diagnostic approach for differentiating between the various causes of Abnormal Uterine Bleeding (AUB) in perimenopausal women?
A: Diagnosing the underlying cause of AUB, particularly in perimenopausal women, requires a systematic approach. Begin with a thorough history, including menstrual cycle characteristics, associated symptoms (e.g., pelvic pain, bloating), and relevant medical history. Physical examination should assess for uterine size, shape, and adnexal masses. Transvaginal ultrasound is crucial for evaluating endometrial thickness and identifying structural abnormalities like fibroids or polyps. Consider endometrial biopsy, especially in women over 45 or with risk factors for endometrial hyperplasia or cancer, to rule out malignancy. Other diagnostic tools like sonohysterography or hysteroscopy may be indicated depending on initial findings. For women approaching menopause, hormonal evaluation (FSH, LH, estradiol) can be informative. Explore how a structured diagnostic algorithm can streamline AUB evaluation in your practice.
Q: How can clinicians effectively manage heavy menstrual bleeding (Menorrhagia) while minimizing the need for surgical interventions like hysterectomy?
A: Managing menorrhagia conservatively often begins with medical therapies. First-line options include combined oral contraceptives (COCs) or progestin-only methods like the levonorgestrel-releasing intrauterine system (LNG-IUS) to regulate the menstrual cycle and reduce bleeding. Tranexamic acid, an antifibrinolytic agent, can be utilized during menses to control heavy bleeding episodes. Nonsteroidal anti-inflammatory drugs (NSAIDs) can also provide symptomatic relief. For women with specific underlying causes like fibroids, targeted therapies such as GnRH agonists may be considered. However, long-term use of GnRH agonists is often limited due to potential side effects. If medical management fails, minimally invasive procedures like endometrial ablation or uterine artery embolization can be explored before considering hysterectomy. Consider implementing a shared decision-making approach with patients to tailor treatment strategies based on individual preferences and clinical circumstances. Learn more about the long-term outcomes associated with various AUB treatments.
Patient presents with abnormal uterine bleeding (AUB), also known as dysfunctional uterine bleeding (DUB), characterized by [frequency, duration, and flow of bleeding; e.g., prolonged menses lasting greater than seven days, heavy menstrual bleeding (menorrhagia) with saturation of one pad or tampon per hour, frequent bleeding occurring less than 21 days apart, intermenstrual bleeding, or postmenopausal bleeding]. Differential diagnosis includes endometrial hyperplasia, endometrial polyps, uterine fibroids, adenomyosis, von Willebrand disease, coagulopathy, and malignancy. Patient reports [associated symptoms such as pelvic pain, cramping, fatigue, dizziness, or lightheadedness]. Physical examination reveals [relevant findings; e.g., normal-sized uterus on bimanual exam, no adnexal masses]. Pelvic ultrasound was ordered to evaluate for structural abnormalities. Laboratory studies including complete blood count (CBC) with hemoglobin and hematocrit, coagulation profile, and thyroid stimulating hormone (TSH) were obtained. Initial management includes [medical or surgical interventions; e.g., hormonal therapy with combined oral contraceptives, progestin-only pills, levonorgestrel intrauterine device (LNG-IUD), tranexamic acid for symptomatic relief, or endometrial ablation]. Patient education provided on AUB causes, diagnostic workup, treatment options, and potential complications. Follow-up scheduled to assess treatment response and discuss further management as needed. ICD-10 code [N92.0, N92.1, or other appropriate code] assigned.